Close Menu

OICR

Pfizer enlisted the help of Ontario researchers to find molecular signatures that can be used to personalize treatments in its pipeline for colorectal cancer.

Two Ontario cancer institutes will use the support to seek biomarkers for colorectal cancer.

Short Reads: Mar 31, 2009

Premium

Helicos, Agencourt, Illumina, RainDance Technologies, Ontario Institute for Cancer Research, VWR International, ZyGem, University of Queensland, University of Michigan, Genomatix

Australia's National Health and Medical Research Council has awarded the University of Queensland about US$19.3 million to support it's cancer genome sequencing project aimed at characterizing pancreatic and ovarian cancers.

Snippets: Feb 25, 2009

Premium

Myriad Genetics, Kinaxo Biotechnologies, Bavarian Research Foundation, European Commission, Decode Genetics, Ontario Institute for Cancer Research

In an online commentary in CMAJ, an OICR official argues that if Canada's support of personalized medicine can't compete with other regions, the country will lose commercialization opportunities.

A team of Ontario researchers has identified a six-gene signature that can help predict non-small cell lung cancer outcomes — and uncovered evidence that there may be thousands of alternative prognostic signatures for the disease.

Pages

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.